title: Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.
authors.affiliation: Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA.
authors.forename: Annapoorna S
authors.initials: AS
authors.lastname: Kini
authors.forename: Cristina A
authors.initials: CA
authors.lastname: Mitre
authors.forename: Mazullah
authors.initials: M
authors.lastname: Kamran
authors.forename: Javed
authors.initials: J
authors.lastname: Suleman
authors.forename: Michael
authors.initials: M
authors.lastname: Kim
authors.forename: Mary E
authors.initials: ME
authors.lastname: Duffy
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Marmur
authors.forename: Samin K
authors.initials: SK
authors.lastname: Sharma
mesh_terms: D000368:Aged; D017225:Atherectomy, Coronary; D006328:Cardiac Catheterization; D003287:Contrast Media / Q000009:adverse effects*; D003928:Diabetic Nephropathies / Q000150:complications*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005260:Female; D018818:Fenoldopam / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D012307:Risk Factors; D015607:Stents; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
chemical_list: D003287:Contrast Media; D018491:Dopamine Agonists; D014283:Triiodobenzoic Acids; D018818:Fenoldopam; C054871:ioversol